31 julio 2015
Two commonly used gout medications, which target uric acid and adenosine triphosphate, may offer protection from alcohol-induced liver disease and inflammation, new research suggests. These findings suggest that clinical trials in humans with alcoholic liver disease should be considered.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/BwzYfHVUzmw» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/BwzYfHVUzmw/150731182656.htm
